Pages that link to "Q35203409"

The following pages link to A blood-based algorithm for the detection of Alzheimer's disease (Q35203409):

Displaying 44 items.

• Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research (Q24289435) (← links)
• Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges (Q24289443) (← links)
• Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology (Q26774743) (← links)
• A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI (Q28741766) (← links)
• Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. (Q33652456) (← links)
• Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender (Q34364200) (← links)
• Developing novel blood-based biomarkers for Alzheimer's disease (Q34394080) (← links)
• A depressive endophenotype of mild cognitive impairment and Alzheimer's disease (Q34851404) (← links)
• Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues (Q35456060) (← links)
• Molecular neuropsychology: creation of test-specific blood biomarker algorithms (Q35456265) (← links)
• Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach. (Q35559746) (← links)
• Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease (Q35812498) (← links)
• Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci? (Q35857246) (← links)
• Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease (Q36472899) (← links)
• Biomarkers of Alzheimer's disease among Mexican Americans. (Q36716970) (← links)
• The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease. (Q36873936) (← links)
• Molecular markers of neuropsychological functioning and Alzheimer's disease (Q36926716) (← links)
• Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. (Q36933725) (← links)
• Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers (Q36934163) (← links)
• Risk factors for mild cognitive impairment among Mexican Americans (Q37079726) (← links)
• A blood screening test for Alzheimer's disease (Q37085325) (← links)
• Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans (Q37248571) (← links)
• Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics. (Q37342809) (← links)
• The Hachinski ischemic scale and cognition: the influence of ethnicity. (Q37725833) (← links)
• Plasma biomarkers for Alzheimer's disease: much needed but tough to find (Q38037157) (← links)
• Biomarkers in Sporadic and Familial Alzheimer's Disease (Q38592041) (← links)
• Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load. (Q40139851) (← links)
• Molecular markers of amnestic mild cognitive impairment among Mexican Americans. (Q40457858) (← links)
• Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans (Q40506191) (← links)
• A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort (Q42630263) (← links)
• Blood-based protein biomarkers for diagnosis of Alzheimer disease (Q47378944) (← links)
• Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry (Q47587631) (← links)
• Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus (Q49165122) (← links)
• Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly. (Q50221800) (← links)
• Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease (Q50553594) (← links)
• Evolving Relevance of Neuroproteomics in Alzheimer's Disease (Q50999408) (← links)
• Multiplexing and multivariate analysis in neurodegeneration (Q51408793) (← links)
• Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement. (Q53446502) (← links)
• Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese (Q60950950) (← links)
• Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers (Q64059925) (← links)
• Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study (Q64069554) (← links)
• A proteomic signature for dementia with Lewy bodies (Q64085064) (← links)
• A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease. (Q64943218) (← links)
• Levels of α-2 Macroglobulin in cognitively normal Mexican- Americans with Subjective Cognitive Decline: A HABLE Study (Q91806770) (← links)